Which has preferable earnings & valuation, ITGR or BDSX?

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.85B 2.29 $102.81M $3.66 34.19 Biodesix $102.94M 2.38 -$35.26M -$3.17 N/A

Is ITGR or BDSX more profitable?

Integer has a net margin of 6.97% compared to Biodesix's net margin of -26.97%. Integer's return on equity of 12.79% beat Biodesix's return on equity. Company Net Margins Return on Equity Return on Assets Integer 6.97% 12.79% 6.48% Biodesix -26.97% -788.19% -30.33%

Does the media prefer ITGR or BDSX?

In the previous week, Biodesix had 18 more articles in the media than Integer. MarketBeat recorded 19 mentions for Biodesix and 1 mentions for Integer. Biodesix's average media sentiment score of 1.43 beat Integer's score of 1.39 indicating that Biodesix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Biodesix 11 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, ITGR or ELV?

Elevance Health has higher revenue and earnings than Integer. Elevance Health is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.85B 2.29 $102.81M $3.66 34.19 Elevance Health $199.13B 0.43 $5.66B $22.50 17.36

Does the media refer more to ITGR or ELV?

In the previous week, Elevance Health had 25 more articles in the media than Integer. MarketBeat recorded 26 mentions for Elevance Health and 1 mentions for Integer. Elevance Health's average media sentiment score of 1.59 beat Integer's score of 1.39 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Elevance Health 24 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor ITGR or BAX?

In the previous week, Baxter International had 6 more articles in the media than Integer. MarketBeat recorded 7 mentions for Baxter International and 1 mentions for Integer. Integer's average media sentiment score of 1.39 beat Baxter International's score of 1.00 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Baxter International 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, ITGR or PEN?

Penumbra has lower revenue, but higher earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.85B 2.29 $102.81M $3.66 34.19 Penumbra $1.40B 9.17 $177.69M $4.07 80.31

Is ITGR or PEN more profitable?

Penumbra has a net margin of 10.67% compared to Integer's net margin of 6.97%. Integer's return on equity of 12.79% beat Penumbra's return on equity. Company Net Margins Return on Equity Return on Assets Integer 6.97% 12.79% 6.48% Penumbra 10.67% 10.50% 8.17%

Does the media prefer ITGR or PEN?

In the previous week, Penumbra had 3 more articles in the media than Integer. MarketBeat recorded 4 mentions for Penumbra and 1 mentions for Integer. Integer's average media sentiment score of 1.39 beat Penumbra's score of 0.98 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Penumbra 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, SNN or ITGR?

Smith & Nephew SNATS has higher revenue and earnings than Integer. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Smith & Nephew SNATS $6.30B 1.98 $625M N/A N/A Integer $1.85B 2.29 $102.81M $3.66 34.19

Does the media prefer SNN or ITGR?

In the previous week, Smith & Nephew SNATS had 5 more articles in the media than Integer. MarketBeat recorded 6 mentions for Smith & Nephew SNATS and 1 mentions for Integer. Integer's average media sentiment score of 1.39 beat Smith & Nephew SNATS's score of 0.55 indicating that Integer is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Smith & Nephew SNATS 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Integer 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Integer (ITGR) Competitors

$125.13 -0.13 (-0.10%)

Closing price 08/17/2026 03:58 PM Eastern

Extended Trading

$125.16 +0.03 (+0.02%)

As of 08:27 AM Eastern

Compare

ITGR vs. BDSX, ELV, BAX, PEN, and SNN

Should you buy Integer stock or one of its competitors? Integer's main competitors and comparable companies include Biodesix (BDSX), Elevance Health (ELV), Baxter International (BAX), Penumbra (PEN), and Smith & Nephew SNATS (SNN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Integer compare to Biodesix?

Integer (NYSE:ITGR) and Biodesix (NASDAQ:BDSX) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

99.3% of Integer shares are owned by institutional investors. Comparatively, 21.0% of Biodesix shares are owned by institutional investors. 1.1% of Integer shares are owned by company insiders. Comparatively, 23.2% of Biodesix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Biodesix had 18 more articles in the media than Integer. MarketBeat recorded 19 mentions for Biodesix and 1 mentions for Integer. Biodesix's average media sentiment score of 1.43 beat Integer's score of 1.39 indicating that Biodesix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Biodesix	11 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Integer has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, Biodesix has a beta of 0.56, meaning that its share price is 44% less volatile than the broader market.

Integer has a net margin of 6.97% compared to Biodesix's net margin of -26.97%. Integer's return on equity of 12.79% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
Biodesix	-26.97%	-788.19%	-30.33%

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.29	$102.81M	$3.66	34.19
Biodesix	$102.94M	2.38	-$35.26M	-$3.17	N/A

Integer presently has a consensus target price of $109.86, indicating a potential downside of 12.21%. Biodesix has a consensus target price of $31.33, indicating a potential upside of 34.77%. Given Biodesix's stronger consensus rating and higher possible upside, analysts clearly believe Biodesix is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
Biodesix	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.80

Summary

Integer beats Biodesix on 9 of the 17 factors compared between the two stocks.

How does Integer compare to Elevance Health?

Integer (NYSE:ITGR) and Elevance Health (NYSE:ELV) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, media sentiment, profitability, dividends, risk and institutional ownership.

Integer has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.68, suggesting that its share price is 32% less volatile than the broader market.

Elevance Health has higher revenue and earnings than Integer. Elevance Health is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.29	$102.81M	$3.66	34.19
Elevance Health	$199.13B	0.43	$5.66B	$22.50	17.36

99.3% of Integer shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 1.1% of Integer shares are held by insiders. Comparatively, 0.3% of Elevance Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Integer has a net margin of 6.97% compared to Elevance Health's net margin of 2.47%. Elevance Health's return on equity of 14.64% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
Elevance Health	2.47%	14.64%	5.22%

Integer currently has a consensus target price of $109.86, suggesting a potential downside of 12.21%. Elevance Health has a consensus target price of $440.90, suggesting a potential upside of 12.85%. Given Elevance Health's stronger consensus rating and higher probable upside, analysts clearly believe Elevance Health is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
Elevance Health	0 Sell rating(s)	8 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.65

In the previous week, Elevance Health had 25 more articles in the media than Integer. MarketBeat recorded 26 mentions for Elevance Health and 1 mentions for Integer. Elevance Health's average media sentiment score of 1.59 beat Integer's score of 1.39 indicating that Elevance Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Elevance Health	24 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Elevance Health beats Integer on 10 of the 16 factors compared between the two stocks.

How does Integer compare to Baxter International?

Integer (NYSE:ITGR) and Baxter International (NYSE:BAX) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

In the previous week, Baxter International had 6 more articles in the media than Integer. MarketBeat recorded 7 mentions for Baxter International and 1 mentions for Integer. Integer's average media sentiment score of 1.39 beat Baxter International's score of 1.00 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Baxter International	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Integer presently has a consensus target price of $109.86, suggesting a potential downside of 12.21%. Baxter International has a consensus target price of $22.45, suggesting a potential downside of 13.27%. Given Integer's stronger consensus rating and higher probable upside, analysts plainly believe Integer is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
Baxter International	2 Sell rating(s)	9 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

99.3% of Integer shares are owned by institutional investors. Comparatively, 90.2% of Baxter International shares are owned by institutional investors. 1.1% of Integer shares are owned by company insiders. Comparatively, 0.2% of Baxter International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Integer has a beta of 0.61, suggesting that its stock price is 39% less volatile than the broader market. Comparatively, Baxter International has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market.

Integer has a net margin of 6.97% compared to Baxter International's net margin of -9.27%. Baxter International's return on equity of 16.57% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
Baxter International	-9.27%	16.57%	5.24%

Integer has higher earnings, but lower revenue than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.29	$102.81M	$3.66	34.19
Baxter International	$11.24B	1.19	-$957M	-$2.07	N/A

Summary

Integer beats Baxter International on 12 of the 16 factors compared between the two stocks.

How does Integer compare to Penumbra?

Integer (NYSE:ITGR) and Penumbra (NYSE:PEN) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability, media sentiment and institutional ownership.

Penumbra has lower revenue, but higher earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.29	$102.81M	$3.66	34.19
Penumbra	$1.40B	9.17	$177.69M	$4.07	80.31

Integer presently has a consensus target price of $109.86, suggesting a potential downside of 12.21%. Penumbra has a consensus target price of $367.07, suggesting a potential upside of 12.30%. Given Penumbra's stronger consensus rating and higher possible upside, analysts clearly believe Penumbra is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
Penumbra	1 Sell rating(s)	13 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.12

In the previous week, Penumbra had 3 more articles in the media than Integer. MarketBeat recorded 4 mentions for Penumbra and 1 mentions for Integer. Integer's average media sentiment score of 1.39 beat Penumbra's score of 0.98 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Penumbra	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

99.3% of Integer shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 1.1% of Integer shares are owned by company insiders. Comparatively, 2.9% of Penumbra shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Integer has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, Penumbra has a beta of 0.7, meaning that its share price is 30% less volatile than the broader market.

Penumbra has a net margin of 10.67% compared to Integer's net margin of 6.97%. Integer's return on equity of 12.79% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
Penumbra	10.67%	10.50%	8.17%

Summary

Penumbra beats Integer on 12 of the 16 factors compared between the two stocks.

How does Integer compare to Smith & Nephew SNATS?

Smith & Nephew SNATS (NYSE:SNN) and Integer (NYSE:ITGR) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

In the previous week, Smith & Nephew SNATS had 5 more articles in the media than Integer. MarketBeat recorded 6 mentions for Smith & Nephew SNATS and 1 mentions for Integer. Integer's average media sentiment score of 1.39 beat Smith & Nephew SNATS's score of 0.55 indicating that Integer is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Smith & Nephew SNATS	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

25.6% of Smith & Nephew SNATS shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 1.0% of Smith & Nephew SNATS shares are owned by insiders. Comparatively, 1.1% of Integer shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Smith & Nephew SNATS currently has a consensus price target of $30.93, suggesting a potential upside of 4.16%. Integer has a consensus price target of $109.86, suggesting a potential downside of 12.21%. Given Smith & Nephew SNATS's higher probable upside, equities research analysts clearly believe Smith & Nephew SNATS is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew SNATS	2 Sell rating(s)	6 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07

Integer has a net margin of 6.97% compared to Smith & Nephew SNATS's net margin of 0.00%. Integer's return on equity of 12.79% beat Smith & Nephew SNATS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smith & Nephew SNATS	N/A	N/A	N/A
Integer	6.97%	12.79%	6.48%

Smith & Nephew SNATS has a beta of 0.55, meaning that its stock price is 45% less volatile than the broader market. Comparatively, Integer has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market.

Smith & Nephew SNATS has higher revenue and earnings than Integer.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew SNATS	$6.30B	1.98	$625M	N/A	N/A
Integer	$1.85B	2.29	$102.81M	$3.66	34.19

Summary

Integer beats Smith & Nephew SNATS on 9 of the 14 factors compared between the two stocks.

Get Integer News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ITGR vs. The Competition

Export

Metric	Integer	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$4.26B	$5.89B	$7.03B	$24.32B
Dividend Yield	N/A	1.75%	2.56%	3.69%
P/E Ratio	34.19	26.51	270.85	30.50
Price / Sales	2.29	65.17	559.55	20.14
Price / Cash	12.08	33.83	28.87	20.48
Price / Book	2.51	6.03	11.07	4.92
Net Income	$102.81M	$148.46M	$3.45B	$1.07B
7 Day Performance	0.07%	-0.26%	0.60%	0.13%
1 Month Performance	30.94%	4.26%	2.07%	2.60%
1 Year Performance	18.49%	8.11%	61.59%	18.42%

Integer Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ITGR Integer	2.5758 of 5 stars	$125.13 -0.1%	$109.86 -12.2%	+17.1%	$4.26B	$1.85B	34.19	11,000	Positive News
BDSX Biodesix	4.6583 of 5 stars	$23.63 -4.9%	$31.33 +32.6%	+193.3%	$249.30M	$88.50M	N/A	220	Positive News
ELV Elevance Health	4.9212 of 5 stars	$395.88 -0.5%	$440.90 +11.4%	+26.5%	$85.85B	$199.13B	17.59	97,100	News Coverage Positive News
BAX Baxter International	1.607 of 5 stars	$27.83 +0.2%	$22.45 -19.3%	+7.0%	$14.39B	$11.24B	N/A	37,500
PEN Penumbra	3.1702 of 5 stars	$325.76 -0.1%	$367.07 +12.7%	+29.2%	$12.83B	$1.40B	80.05	4,700

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ITGR) was last updated on 8/18/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Integer (ITGR) Competitors

ITGR vs. BDSX, ELV, BAX, PEN, and SNN

How does Integer compare to Biodesix?

Summary

How does Integer compare to Elevance Health?

Summary

How does Integer compare to Baxter International?

Summary

How does Integer compare to Penumbra?

Summary

How does Integer compare to Smith & Nephew SNATS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ITGR vs. The Competition

Integer Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Integer (ITGR) Competitors

ITGR vs. BDSX, ELV, BAX, PEN, and SNN

How does Integer compare to Biodesix?

Do institutionals and insiders have more ownership in ITGR or BDSX?

Does the media prefer ITGR or BDSX?

Which has more risk and volatility, ITGR or BDSX?

Is ITGR or BDSX more profitable?

Which has preferable earnings & valuation, ITGR or BDSX?

Do analysts rate ITGR or BDSX?

Summary

How does Integer compare to Elevance Health?

Which has more risk & volatility, ITGR or ELV?

Which has preferable valuation and earnings, ITGR or ELV?

Do insiders & institutionals hold more shares of ITGR or ELV?

Is ITGR or ELV more profitable?

Do analysts rate ITGR or ELV?

Does the media refer more to ITGR or ELV?

Summary

How does Integer compare to Baxter International?

Does the media favor ITGR or BAX?

Do analysts prefer ITGR or BAX?

Do institutionals & insiders hold more shares of ITGR or BAX?

Which has more volatility & risk, ITGR or BAX?

Is ITGR or BAX more profitable?

Which has preferable valuation and earnings, ITGR or BAX?

Summary

How does Integer compare to Penumbra?

Which has stronger valuation and earnings, ITGR or PEN?

Do analysts recommend ITGR or PEN?

Does the media prefer ITGR or PEN?

Do insiders and institutionals hold more shares of ITGR or PEN?

Which has more risk and volatility, ITGR or PEN?

Is ITGR or PEN more profitable?

Summary

How does Integer compare to Smith & Nephew SNATS?

Does the media prefer SNN or ITGR?

Do insiders & institutionals hold more shares of SNN or ITGR?

Do analysts recommend SNN or ITGR?

Is SNN or ITGR more profitable?

Which has more volatility and risk, SNN or ITGR?

Which has better earnings & valuation, SNN or ITGR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ITGR vs. The Competition

Integer Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools